Patron Exim IPO: The public subscription period for Patron Exim Limited’s initial public offering (IPO) will begin on Tuesday, February 21, 2023, and the three-day first share sale is planned to end on Friday, February 24, 2023. The company’s shares are anticipated to be listed on BSE SME on Monday, March 6, 2023.
Patron Exim IPO: Price band, allocation, and listing date
Patron Exim’s initial public offering (IPO) is priced at 27 per share, based on a Face Value (FV) of 10 and a Net Asset Value (NAV) of 17, with an issue size of 16.69 crore. The proceeds from the public sale will be allocated to working capital, general corporate goals, and public issue expenses. The exchanges’ SME platform is designed for small and medium-sized businesses.
This SME IPO of 6,180,000 equity shares with a par value of 10 totals 16,690,000,000. The minimum quantity per order is 4000 shares. The finalisation of the share allocation basis for this public offering is anticipated to occur on March 1, 2023. Bigshare Services Pvt. Ltd. is the issue’s registrar.
Macfos IPO Sees Strong Demand from Retail Investors; GMP, Subscription Status on Day 2
About Patron Exim
Ahmedabad-based Patron Exim is part of a wide group of companies that also includes Cedac Medicorp, Evoque Remedies, Earum Pharmaceuticals, Auxilia Pharmaceuticals, Madrid Diamonds, Atlantis Exim, and N G Overseas, among others. The Group of Companies principally engages within the pharmaceutical, chemical, and allied industries.
The company trades and distributes a variety of pharmaceutical raw materials, generally known as APIs (Active Pharmaceutical Ingredients), industrial chemicals, excipients, and solvents. The company’s promoters are Narendrakumar Gangaramdas Patel and Sushilabahen Narendrakumar Patel.
